INS and gestational diabetes: Other studies confirmed our results: The studies by Tocci et al., Tarry-Adkins, Ozanne, and Aiken and Rowan et al. found no significant difference in the rate of preterm birth (birth before 37 weeks) between women with GDM who received metformin therapy and those who received insulin therapy [21–23].